Cancer Genetics Inc (NASDAQ:CGIX)’s share price shot up 8.6% during trading on Monday . The stock traded as high as $2.20 and last traded at $1.90. 510,910 shares were traded during trading, an increase of 281% from the average session volume of 133,932 shares. The stock had previously closed at $1.75.
Several brokerages have commented on CGIX. HC Wainwright set a $6.00 price target on Cancer Genetics and gave the company a “buy” rating in a report on Tuesday, February 6th. ValuEngine upgraded Cancer Genetics from a “strong sell” rating to a “sell” rating in a report on Friday, February 2nd. Maxim Group set a $6.00 price target on Cancer Genetics and gave the company a “buy” rating in a report on Wednesday, December 13th. Finally, Zacks Investment Research upgraded shares of Cancer Genetics from a “sell” rating to a “hold” rating in a research note on Wednesday, November 29th. One equities research analyst has rated the stock with a sell rating, two have given a hold rating and three have assigned a buy rating to the stock. The company presently has an average rating of “Hold” and an average price target of $5.56.
The firm has a market cap of $48.48, a P/E ratio of -1.96 and a beta of 1.24. The company has a debt-to-equity ratio of 0.18, a current ratio of 2.01 and a quick ratio of 2.01.
WARNING: “Cancer Genetics (CGIX) Shares Up 8.6%” was reported by StockNewsTimes and is the property of of StockNewsTimes. If you are accessing this piece on another website, it was illegally copied and republished in violation of U.S. and international trademark & copyright law. The legal version of this piece can be read at https://stocknewstimes.com/2018/03/19/cancer-genetics-cgix-shares-up-8-6.html.
Cancer Genetics Company Profile
Cancer Genetics, Inc is a United States-based company, which is engaged in the field of personalized medicine. The Company offers diagnostic products and services that enable precision medicine in the field of oncology through molecular markers and diagnostics. The Company offers a range of laboratory services that provide genomic and biomarker information.
Receive News & Ratings for Cancer Genetics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cancer Genetics and related companies with MarketBeat.com's FREE daily email newsletter.